Epistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSA
Related Experiment Video
Updated: Feb 7, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Maho Yokoyama1, Emily Stevens2, Maisem Laabei3
1Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, UK.
Background:
Fitness costs imposed on bacteria by antibiotic resistance mechanisms are believed to hamper their dissemination. The scale of these costs is highly variable. Some, including resistance of Staphylococcus aureus to the clinically important antibiotic mupirocin, have been reported as being cost-free, which suggests that there are few barriers preventing their global spread. However, this is not supported by surveillance data in healthy communities, which indicate that this resistance mechanism is relatively unsuccessful.
Results:
Epistasis analysis on two collections of MRSA provides an explanation for this discord, where the mupirocin resistance-conferring mutation of the ileS gene appears to affect the levels of toxins produced by S. aureus when combined with specific polymorphisms at other loci. Proteomic analysis demonstrates that the activity of the secretory apparatus of the PSM family of toxins is affected by mupirocin resistance. As an energetically costly activity, this reduction in toxicity masks the fitness costs associated with this resistance mutation, a cost that becomes apparent when toxin production becomes necessary. This hidden fitness cost provides a likely explanation for why this mupirocin-resistance mechanism is not more prevalent, given the widespread use of this antibiotic.
Conclusions:
With dwindling pools of antibiotics available for use, information on the fitness consequences of the acquisition of resistance may need to be considered when designing antibiotic prescribing policies. However, this study suggests there are levels of depth that we do not understand, and that holistic, surveillance and functional genomics approaches are required to gain this crucial information.
Insights
Mupirocin resistance in Staphylococcus aureus is not cost-free, despite initial assumptions. A hidden fitness cost related to toxin production explains why this antibiotic resistance is not more widespread.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Antibiotic resistance mechanisms often impose fitness costs on bacteria, potentially limiting their spread.
- Mupirocin resistance in Staphylococcus aureus was previously thought to be cost-free, suggesting few barriers to its dissemination.
- However, surveillance data contradicts this, indicating limited success of this resistance mechanism in healthy communities.
Purpose of the Study:
- To investigate the apparent discordance between the presumed cost-free nature of mupirocin resistance and its limited prevalence.
- To elucidate the underlying molecular mechanisms explaining the fitness consequences of mupirocin resistance in Staphylococcus aureus.
Main Methods:
- Epistasis analysis of two MRSA collections.
- Proteomic analysis of toxin production.
- Investigation of the ileS gene and its interaction with other genetic polymorphisms.
Main Results:
- Mupirocin resistance-conferring mutations in the ileS gene interact with other genetic polymorphisms.
- These interactions affect the production levels of the PSM family of toxins.
- Reduced toxin production masks the true fitness cost of mupirocin resistance, especially when toxin production is essential.
Conclusions:
- A hidden fitness cost, linked to reduced toxin production, explains the limited prevalence of mupirocin resistance.
- Understanding fitness consequences is crucial for antibiotic prescribing policies, especially with dwindling antibiotic options.
- Holistic approaches combining surveillance and functional genomics are necessary for a comprehensive understanding of antibiotic resistance.
More Related Videos
Related Concept Videos
Epistasis
Epistasis Analysis
Development of Antibiotic Resistance
The Evidence for Evolution
Antibiotic Selection
Convergent Evolution

